These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15038253)

  • 1. Lipid-lowering therapy. New and established agents reduce risk of cardiovascular events.
    Smith CR
    Postgrad Med; 2004 Mar; 115(3):29-30, 33-6. PubMed ID: 15038253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying pleiotropic effects of statins.
    Palaniswamy C; Selvaraj DR; Selvaraj T; Sukhija R
    Am J Ther; 2010; 17(1):75-8. PubMed ID: 19451808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Differences in the Cholesterol-Lowering Effect of Statin.
    Naito R; Miyauchi K; Daida H
    J Atheroscler Thromb; 2017 Jan; 24(1):19-25. PubMed ID: 27733728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and non-lipid effects of statins.
    Paoletti R; Bolego C; Cignarella A
    Handb Exp Pharmacol; 2005; (170):365-88. PubMed ID: 16596807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the cholesterol-lowering properties of statins affect cancer risk?
    Solomon KR; Freeman MR
    Trends Endocrinol Metab; 2008; 19(4):113-21. PubMed ID: 18356074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
    Albert MA; Danielson E; Rifai N; Ridker PM;
    JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins: safety and pharmacological interactions.
    Di Girolamo G; González C
    Expert Opin Drug Saf; 2012 Nov; 11(6):889-91. PubMed ID: 23043327
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.
    Ginsberg HN
    J Clin Endocrinol Metab; 2006 Feb; 91(2):383-92. PubMed ID: 16291700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
    Liao JK
    Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The past, present, and future of statin therapy.
    Watson KE; Fonarow GC
    Rev Cardiovasc Med; 2005; 6(3):129-39. PubMed ID: 16195686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins: pros and cons.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Med Clin (Barc); 2018 May; 150(10):398-402. PubMed ID: 29292104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of statins: do they matter?
    Gotto AM; Farmer JA
    Curr Opin Lipidol; 2001 Aug; 12(4):391-4. PubMed ID: 11507323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.